Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis

Controlled Clinical Trials

Volumn 18, Issue 6, 1997, Pages 580-593

  Pogue, Janice M ^a   Yusuf, Salim ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HGH McMaster Clinic   (Canada)

Author keywords

Magnesium; Meta analysis; Myocardial infarction; Randomized controlled trials; Stochastic processes; Streptokinase; Thrombolytic therapy

Indexed keywords

MAGNESIUM; STREPTOKINASE;

BLOOD CLOT LYSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

FIBRINOLYTIC AGENTS; HUMANS; MAGNESIUM; META-ANALYSIS; METHODS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; STOCHASTIC PROCESSES; STREPTOKINASE;

EID: 0030703712     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(97)00051-2     Document Type: Conference Paper

References (61)

1. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-254.
2. Furberg CT, Morgan TM. Lessons from overviews of cardiovascular trials. Stat Med 1987;6:295-303.
3. Chalmers TC. Problems induced by meta-analysis. Stat Med 1991 ;10:971-980.
4. Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA 1992;268:240-248.
5. Olkin I. Meta-analysis: reconciling the results of independent studies. Stat Med 1995;14:457-472.
6. Armitage P. Inference and decision in clinical trials. J Clin Epidemiol 1989;42:293-299.
7. Freedman LS, Spiegelhalter DJ, Parmar MKB. The what, why and how of Bayesian trials monitoring. Stat Med 1994;13:1371-1383.
8. McPherson K. Statistics: the problem of examining accumulating data more than once. N Engl J Med 1974;290:501-502.
9. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977;64:191-199.
10. Canner PL. Monitoring treatment differences in long-term clinical trials. Biometrics 1977;33:603-615.
11. O'Brien PC. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-556.
12. Slud E, Wei LJ. Two sample repeated significance tests based on the modified Wilcoxon statistic. JASA 1982;77:862-868.
13. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-663.
14. Halperin M, Lan KKG, Ware JH, et al. An aid to data monitoring in long-term clinical trials. Controlled Clin Trials 1982;3:311-323.
15. DeMets DL. Practical aspects in data monitoring: a brief review. Stat Med 1987; 6:753-760.
16. Fletcher AP, Sherry S, Alkjaersig N, et al. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 1959;38:1111-1119.
17. Dewar HA, Stephenson P, Horler AR, et al. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases. Br Med J 1963;1:915-920.
18. Amery A, Roever G, Vermeulen HJ, et al. Single-blind randomized multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction. Acta Med Scand Suppl 1969;505:5-35.
19. European Working Party. Streptokinase in recent myocardial infarction: a controlled multicentre trial. Er Med J 1971;iii:325-331.
20. Heikenheimo R, Ahrenberg P, Honkapohja, et al. Fibrinolytic treatment in acute myocardial infarction. Acta Med Scand 1971;189:7-13.
21. Dioguardi N, Mannucci PM, Lotto A, et al. Controlled trial of streptokinase and heparin in acute myocardial infarction. Lancet 1971;ii:891-895.
22. Bett JHN, Biggs JC, Castaldi PA, et al. Australian multicentre trial of streptokinase in acute myocardial infarction. Lancet 1973;i:57-60.
23. Breddin K, Ehrly AM, Fechler L, et al. Die kurzzeitfibrinolyse beim akuten myokardinfarkt. Dtsch Med Wochenschr 1973;98:861-873.
24. Ness PM, Simon TL, Cole C, Walston A. A pilot study of streptokinase therapy in acute myocardial infarction: observations on complications and relation to trial design. Am Heart J 1974;88:705-712.
25. Frank (Zielinski) B. Traitement de l'infarctus du myocarde par la streptokinase. These pour le Doctorat en Medecine, Faculte de Medecine, Bichat-Beaujon, Universite Paris VII. 1975.
26. Valere PE, Guerot C, Castillo-Fenoy A, et al. L'infarctus myocardique. Traitement randomise par la streptokinase. La Nouvelle Presse medicale 1975;4:190.
27. Klein W, Pavek P, Brandt D, et al. Resultate einer doppelblindstudie beim myofardianfarkt. In: Sailer S, ed. Die Fibriolysebehandlung des Akuten Myofardinfarktes. Wien: Verlag Bruder Hollinek; 1976, pp 65-73.
28. Aber CP, Bass NM, Berry CL, et al. Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. Br Med J 1976;2:1100-1104.
29. Benda V, Haider M, Ambrosch P. Ergebnisse der Osterreichoischen hezinfarktstudie mit streptokinase. Results of the Austrian myocardial infarction study of the effects of streptokinase. Wein Klin Wochenschr 1977;89:779-783.
30. Australian Multicentre Trial of Streptokinase in Acute Myocardial Infarction. Med J Aust 1977;1:553.
31. Lasierra C, Vilades J, Fernandez C, et al. Estreptoquinasa en el infarto agudo de miocardio. Revista Clinica Espanola 1977;144:251-257.
32. Poliwoda H, Schneider B, Avnarius HJ. Untersuchungen zum klinischen verlauf des akuten myokardinfarktes. Gemeinschaftsstudie an 26 krankenhausern in Nord Deutschland. Med Klin 1977;72:451-458.
33. Witchitz S, Kolsky H, Moisson P, Chiche P. Streptokinase at infarctus du myocarde aigu. La fibrinolyse peut-elle limiter la nécrose? Ann Cardiol Angélol 1977;26:53-56.
34. European Co-operative Study Group for Streptokinase Treatment in Acute Myocardial Infarction. Streptokinase in acute myocardial infarction. New Engl J Med 1979;301:797-802.
35. The I.S.A.M. Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days. New Eng J Med 1986;314:1465-1471.
36. GISSI. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-402.
37. Olson HG, Butman SM, Piters KM, et al. A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarction. Am Heart J 1986;111: 1021-1029.
38. Baroffio R. Efficacia del trattamento randomizzato con streptochinasi per via sistemica nell'infarto miocardio in evoluzione. Min Cardioang 1986;34:607-614.
39. Schreiber TL, Miller DH, Silvasi DA, et al. Randomized double blind trial of intravenous streptokinase for acute myocardial infarction. Am J Cardiol 1986;58:47-52.
40. Cribier A, Berland J, Saoudi N, et al. Streptokinase intracoronarienne d'accord! . . . Streptokinase intraveineuse, d'abord? Heparine ou streptokinase intraveineuse dans l'infarctus aigu: resultats preliminaires d'une etude prospective et randomisee avec controle angiographique sur 44 patients. Haemostasis 1986;16:127-134.
41. Sainsous J, Bonnet JL, Serradimigni et le groupe SIVIM. Streptokinase intraveineuse versus heparine a la phase aigue de l'infarctus du myocarde. Haemostasis 1986;16(suppl 6):145-152.
42. Durand P, Asseman P, Pruvost P, et al. Effectiveness of intravenous streptokinase on infarct size and left ventricular function in acute myocardial infarction. Prospective and randomized study. Clin Cardiol 1987;10:383-392.
43. White HD, Norris RM, Brown MA, et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. New Engl J Med 1980;317:850-855.
44. Bassand JP, Faivre R, Becque O, et al. Effects of early high-dose streptokinase intravenously on left ventricular function in acute myocardial infarction. Am J Cardiol 1987;60:435-439.
45. Vlay SC, Lawson WE. The safety of combined thrombolysis and β-adrenergic blockade in patients with acute myocardial infarction. Chest 1988;93:716-721.
46. Kennedy JW, Martin GV, Davis KB, et al. The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. Circulation 1988; 77:345-352.
47. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-360.
48. Wisenberg G, Finnie KJ, Jablonsky G, et al. Nuclear magnetic resonance and radionuclide angiographic assessment of acute myocardial infarction in a randomized trial of intravenous streptokinase. Am J Cardiol 1988;62:1011-1016.
49. EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group. Randomized trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993;342:767-772.
50. Teo KK, Yusuf S. Role of magnesium in reducing mortality in acute myocardial infarction. Drugs 1993;46:347-359.
51. Morton BC, Smith FM, McKibbon TG, et al. Magnesium therapy in acute myocardial infarction. Magnesium 1981;1:192-194.
52. Rasmussen HS, McNair P, Norregard P, et al. Intravenous magnesium in acute myocardial infarction. Lancet 1986;i:234-236.
53. Smith LF, Heagerty AM, Bing KF, et al. Intravenous infusion of magnesium sulphate after myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol 1986;12:175-180.
54. Abraham AS, Rosenmann D, Kramer M, et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med 1987;147:753-755.
55. Cremuzynski L, Jurgiel R, Kulakowski P, et al. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulphate. Am Heart J 1989;118:1333-1334.
56. Shechter M, Hod H, Marks N, et al. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990;66:271-274.
57. Singh RB, Sircar AR, Rastogi SS, et al. Magnesium and potassium administration in acute myocardial infarction. Magnesium and Trace Elements 1990;9:198-204.
58. Schector M, Hod H, Kaplinsky E, et al. Magnesium administration in patients with acute myocardial infarction who are not candidates for thrombolysis therapy. Eur Heart J 1991;12:401.
59. Feldstedt M, Boesgaard S, Bouchelouche P, et al. Magnesium substitution in acute ischemic heart syndromes. Eur Heart J 1991;12:1215-1218.
60. Woods KL, Fletcher S, Roffe C, et al. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992;339:1553-1558.
61. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.